$BHST

BioHarvest Sciences Inc. reported its Q4 2025 earnings with a significant increase in revenue driven by strong sales in its cannabis sector. The company's investments in R&D and marketing paid off, with a reported 30% year-on-year growth. Their innovative cultivation techniques and expansion plans into new markets were highlighted as key growth drivers. However, concerns regarding regulatory challenges in the cannabis industry remain prevalent. Overall, the company's positive earnings report positions it for potential growth amidst ongoing market volatility.